BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32868183)

  • 1. Pancreatic body and tail cancer and favorable metastatic lymph node behavior on the left edge of the aorta.
    Tanaka K; Nakamura T; Asano T; Nakanishi Y; Noji T; Tsuchikawa T; Okamura K; Shichinohe T; Hirano S
    Pancreatology; 2020 Oct; 20(7):1451-1457. PubMed ID: 32868183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer.
    Riediger H; Keck T; Wellner U; zur Hausen A; Adam U; Hopt UT; Makowiec F
    J Gastrointest Surg; 2009 Jul; 13(7):1337-44. PubMed ID: 19418101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reappraisal of nodal staging and study of lymph node station involvement in distal pancreatectomy for body-tail pancreatic ductal adenocarcinoma.
    Malleo G; Maggino L; Nobile S; Casciani F; Cacciatori N; Paiella S; Luchini C; Rusev B; Capelli P; Marchegiani G; Bassi C; Salvia R
    Eur J Surg Oncol; 2020 Sep; 46(9):1734-1741. PubMed ID: 32327367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appropriate Lymph Node Dissection Sites for Cancer in the Body and Tail of the Pancreas: A Multicenter Retrospective Study.
    Tanaka K; Kimura Y; Hayashi T; Ambo Y; Yoshida M; Umemoto K; Murakami T; Asano T; Nakamura T; Hirano S
    Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern of lymph node metastasis spread in pancreatic cancer.
    Kanda M; Fujii T; Nagai S; Kodera Y; Kanzaki A; Sahin TT; Hayashi M; Yamada S; Sugimoto H; Nomoto S; Takeda S; Morita S; Nakao A
    Pancreas; 2011 Aug; 40(6):951-5. PubMed ID: 21441841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival.
    Morales-Oyarvide V; Rubinson DA; Dunne RF; Kozak MM; Bui JL; Yuan C; Qian ZR; Babic A; Da Silva A; Nowak JA; Khalaf N; Brais LK; Welch MW; Zellers CL; Ng K; Chang DT; Miksad RA; Bullock AJ; Tseng JF; Swanson RS; Clancy TE; Linehan DC; Findeis-Hosey JJ; Doyle LA; Hornick JL; Ogino S; Fuchs CS; Hezel AF; Koong AC; Wolpin BM
    Br J Cancer; 2017 Dec; 117(12):1874-1882. PubMed ID: 28982112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenocarcinoma of the pancreas: Does prognosis depend on mode of lymph node invasion?
    Buc E; Couvelard A; Kwiatkowski F; Dokmak S; Ruszniewski P; Hammel P; Belghiti J; Sauvanet A
    Eur J Surg Oncol; 2014 Nov; 40(11):1578-85. PubMed ID: 24923739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical impact of the lymph node ratio as a prognostic factor after resection of pancreatic cancer.
    Yamamoto Y; Ikoma H; Morimura R; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
    Anticancer Res; 2014 May; 34(5):2389-94. PubMed ID: 24778048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reappraisal of Nodal Staging and Study of Lymph Node Station Involvement in Pancreaticoduodenectomy with the Standard International Study Group of Pancreatic Surgery Definition of Lymphadenectomy for Cancer.
    Malleo G; Maggino L; Capelli P; Gulino F; Segattini S; Scarpa A; Bassi C; Butturini G; Salvia R
    J Am Coll Surg; 2015 Aug; 221(2):367-79.e4. PubMed ID: 26081176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should a standard lymphadenectomy include the No. 9 lymph nodes for body and tail pancreatic ductal adenocarcinoma?
    Zhou Y; Lin J; Wang W; Chen H; Deng X; Peng C; Cheng D; Shen B
    Pancreatology; 2019 Apr; 19(3):414-418. PubMed ID: 30902419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of lymph node metastases and impact on survival in resected pancreatic neuroendocrine tumors: a single-center experience.
    Wong J; Fulp WJ; Strosberg JR; Kvols LK; Centeno BA; Hodul PJ
    Am J Surg; 2014 Nov; 208(5):775-780. PubMed ID: 24997491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the prognostic factors and significance of lymph node status in invasive ductal carcinoma of the body or tail of the pancreas.
    Fujita T; Nakagohri T; Gotohda N; Takahashi S; Konishi M; Kojima M; Kinoshita T
    Pancreas; 2010 Jan; 39(1):e48-54. PubMed ID: 19910836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which patients with para-aortic lymph node (LN16) metastasis will truly benefit from curative pancreaticoduodenectomy for pancreatic head cancer?
    Liu C; Lu Y; Luo G; Cheng H; Guo M; Liu Z; Xu J; Long J; Liu L; Fu D; Ni Q; Li M; Yu X
    Oncotarget; 2016 May; 7(20):29177-86. PubMed ID: 27081079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic neck cancer has specific and oncologic characteristics regarding portal vein invasion and lymph node metastasis.
    Hirono S; Kawai M; Okada K; Miyazawa M; Shimizu A; Kitahata Y; Ueno M; Yamaue H
    Surgery; 2016 Feb; 159(2):426-40. PubMed ID: 26253244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between the tumor location and clinicopathological features in left-sided pancreatic ductal adenocarcinoma.
    Hirashita T; Iwashita Y; Fujinaga A; Nakanuma H; Masuda T; Endo Y; Ohta M; Inomata M
    Surg Today; 2021 May; 51(5):814-820. PubMed ID: 32970195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph node involvement beyond peripancreatic region in pancreatic head cancers: when results belie expectations.
    Golse N; Lebeau R; Lombard-Bohas C; Hervieu V; Ponchon T; Adham M
    Pancreas; 2013 Mar; 42(2):239-48. PubMed ID: 23038054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of preoperative prognostic factors in patients with resectable pancreatic ductal adenocarcinoma.
    Izumo W; Higuchi R; Furukawa T; Yazawa T; Uemura S; Shiihara M; Yamamoto M
    Scand J Gastroenterol; 2019 Jun; 54(6):780-786. PubMed ID: 31180790
    [No Abstract]   [Full Text] [Related]  

  • 18. A Single-Institution Validation Study of Lymph Node Staging By the AJCC 8th Edition for Patients with Pancreatic Head Cancer: A Proposal to Subdivide the N2 Category.
    Asano D; Nara S; Kishi Y; Esaki M; Hiraoka N; Tanabe M; Shimada K
    Ann Surg Oncol; 2019 Jul; 26(7):2112-2120. PubMed ID: 31037440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma.
    Berger AC; Watson JC; Ross EA; Hoffman JP
    Am Surg; 2004 Mar; 70(3):235-40; discussion 240. PubMed ID: 15055847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different clinical presentations of metachronous pulmonary metastases after resection of pancreatic ductal adenocarcinoma: Retrospective study and review of the literature.
    Lovecek M; Skalicky P; Chudacek J; Szkorupa M; Svebisova H; Lemstrova R; Ehrmann J; Melichar B; Yogeswara T; Klos D; Vrba R; Havlik R; Mohelnikova-Duchonova B
    World J Gastroenterol; 2017 Sep; 23(35):6420-6428. PubMed ID: 29085191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.